The group 2016

Our main research objective is to understand the genomic, epigenomic, and metabolic changes leading to cancer in humans - and identify points of vulnerabilities that can be exploited for cancer therapy. We use various state-of-the-art genomic tools to interrogate tumor behavior, gene alterations and events that are fundamental to cancer development and survival.

We believe that the knowledge obtained on these cancer dependencies will allow us to design novel therapeutic approaches.